The latest plain language summary of publication from Neurodegenerative Disease Management presents the results from the CLARITY and CLARITY Extension studies, which looked at how well cladribine tablets work in treating people with multiple sclerosis.
Read the full article here.
The original article on which this summary is based is called ‘Analysis of frequency and severity of relapses in multiple sclerosis patients treated with cladribine tablets or placebo: The CLARITY and CLARITY Extension studies’ and was originally published in the Multiple Sclerosis Journal. The original article can be read here.